Le Lézard
Classified in: Business, Covid-19 virus
Subject: FINANCING AGREEMENTS

Tidewater Midstream Announces Upsize to Previously Announced Bought Deal Financing


THIS PRESS RELEASE IS NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWS AGENCIES

CALGARY, Alberta, July 28, 2022 (GLOBE NEWSWIRE) -- Tidewater Midstream and Infrastructure Ltd. ("Tidewater" or the "Company") (TSX: TWM) is pleased to announce that it will be upsizing its previously announced bought deal public offering (the "Public Offering") of units ("Units"). Under the Public Offering, a syndicate of underwriters (the "Underwriters"), led by CIBC Capital Markets, National Bank Financial, RBC Capital Markets and ATB Capital Markets, have agreed to buy on a bought deal basis 42,080,000 Units of the Company, at a price of $1.20 per Unit for gross proceeds of $50.5 million. The terms of the previously announced private placement (the "Private Placement") remain unchanged. In total, the Company will issue $85 million of Units at a price of $1.20 per Unit (the "Issue Price") under the Public Offering and Private Placement (collectively the "Offering").

Each Unit will be comprised of one common share of the Company (each a "Common Share") and one-half of one common share purchase warrant (each full warrant, a "Warrant"). Each Warrant will entitle the holder to acquire one Common Share from the Company at a price of $1.44 per Common Share for a period of 24 months following the closing of the Offering.

The Company has granted the Underwriters an option (the "Over-Allotment Option"), exercisable for a period of 30 days following the closing of the Public Offering, to purchase an additional 15% of the Public Offering to cover over-allotments, if any. This Over-Allotment Option may be exercised by the Underwriters for additional Units, Common Shares, Warrants or any combination of such securities (the "Securities"). Should the Over-Allotment Option be exercised, the subscribers under the Private Placement will have the option to purchase on a pro-rata basis additional Securities that are purchased by the Underwriters pursuant to the Over-Allotment Option.

Proceeds from the Offering and other borrowing facilities, will be used to repay Tidewater's existing senior unsecured notes due December 19, 2022 and second lien term loan due October 31, 2022.

The Offering is expected to close on or about August 16, 2022 and closing of each of the Public Offering and Private Placement will be subject to, among other things, customary conditions, the concurrent closing of the other and the Company entering into the expanded senior credit facility. The Offering is subject to the approval of the Toronto Stock Exchange ("TSX").

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful. The securities have not been registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements thereunder.

ABOUT TIDEWATER
Tidewater is traded on the TSX under the symbol "TWM". Tidewater's business objective is to build a diversified midstream and infrastructure company in the North American natural gas, natural gas liquids, crude oil, refined product, and renewable energy value chain. Its strategy is to profitably grow and create shareholder value through the acquisition and development of conventional and renewable energy infrastructure. To achieve its business objective, Tidewater is focused on providing customers with a full service, vertically integrated value chain through the acquisition and development of energy infrastructure, including downstream facilities, natural gas processing facilities, natural gas liquids infrastructure, pipelines, railcars, export terminals, storage, and various renewable initiatives. To complement its infrastructure asset base, the Company also markets crude, refined product, natural gas, NGLs and renewable products and services to customers across North America.

Tidewater is a majority shareholder in Tidewater Renewables, a multi-faceted, energy transition company focusing on the production of low carbon fuels. Tidewater Renewables' common shares are publicly traded on the TSX under the symbol "LCFS".

FURTHER INFORMATION:

For more information, please contact:

Joel Macleod, Chairman & Chief Executive Officer Brian Newmarch, Chief Financial Officer
Tidewater Midstream and Infrastructure Ltd.Tidewater Midstream and Infrastructure Ltd.
Phone: (587) 475-0210Phone: (587) 315-8368
Email: jmacleod@tidewatermidstream.com Email: bnewmarch@tidewatermidstream.com 

FORWARD LOOKING STATEMENTS
Certain statements contained in this press release constitute forward-looking statements and forward-looking information (collectively referred to herein as, "forward-looking statements") within the meaning of applicable Canadian securities laws. Such forward-looking statements relate to future events, conditions or future financial performance of Tidewater based on future economic conditions and courses of action. All statements other than statements of historical fact may be forward-looking statements. Such forward-looking statements are often, but not always, identified by the use of any words such as "seek", "anticipate", "budget", "plan", "continue", "forecast", "estimate", "expect", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe", "will likely result", "are expected to", "will continue", "is anticipated", "believes", "estimated", "intends", "plans", "projection", "outlook" and similar expressions. These statements involve known and unknown risks, assumptions, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this press release should not be unduly relied upon.

In particular, this press release contains forward-looking statements pertaining to but not limited to the following:

Although the forward-looking statements contained in this press release are based upon assumptions which management of the Company believes to be reasonable, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. With respect to forward-looking statements contained in this press release, the Company has assumptions regarding, but not limited to:

The Company's actual results could differ materially from those anticipated in the forward-looking statements, as a result of numerous known and unknown risks and uncertainties and other factors including but not limited to:

The foregoing lists are not exhaustive. Additional information on these and other factors which could affect the Company's operations or financial results are included in the Company's most recent AIF and in other documents on file with the Canadian Securities regulatory authorities.

Management of the Company has included the above summary of assumptions and risks related to forward-looking statements provided in this press release in order to provide holders of common shares in the capital of the Company with a more complete perspective on the Company's current and future operations and such information may not be appropriate for other purposes. The Company's actual results or achievement could differ materially from those expressed in, or implied by, these forward-looking statements and, accordingly, no assurance can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any off them do so, what benefits the Company will derive therefrom. Readers are therefore cautioned that the foregoing list of important factors is not exhaustive, and they should not unduly rely on the forward-looking statements included in this press release. Tidewater does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by applicable securities law. All forward-looking statements contained in this press release are expressly qualified by this cautionary statement. Further information about factors affecting forward-looking statements and management's assumptions and analysis thereof is available in filings made by the Company with Canadian provincial securities commissions available on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com.



These press releases may also interest you

26 jan 2023
NioCorp Developments Ltd. ("NioCorp" or the "Company") today announced that it has entered into definitive agreements with respect to two previously announced financings with YA II PN, Ltd., an investment fund managed by Yorkville Advisors Global,...

26 jan 2023
Winners of the 36th International ARC Awards have been announcement. The 2021 annual report of Fosun International Limited ("Fosun International" or the "Company", HKEX: 00656) won Gold Award in the "Traditional Annual Report" category of the 2022...

26 jan 2023
The "Europe Human Papillomavirus Vaccine Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Dosage, Age, Application, and End User" report has been added to  ResearchAndMarkets.com's offering.   The Europe human papillomavirus...

26 jan 2023
The "True Wireless Stereo Earbuds Market Size, Share, & Trends Analysis Report By Price Band (Below USD 100, USD 100-199, Over USD 200), By Region (APAC, North America), And Segment Forecasts, 2022 - 2030" report has been added to...

26 jan 2023
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the European Medicines Agency (EMA) has accepted a marketing authorization application (MAA) for lecanemab (Brand Name in the U.S.: LEQEMBItm), an...

26 jan 2023
The "Fencing Global Market Report 2022" report has been added to  ResearchAndMarkets.com's offering.   This report provides strategists, marketers and senior management with the critical information they need to assess the global fencing market.The...



News published on 28 july 2022 at 09:40 and distributed by: